We are delighted Â that the distinguished Journal has accepted our letter Â for publication, that will address our thougths on the recently published report on LINX, the magnetic device for gastroesophageal reflux disease (GERD). We have commented on the magnetic device’s short and intermediate term performance Â previously in this blog.
LINX seemed to promise a breakthrough in the treatment of gastro-esophageal reflux disease (GERD) when the one- and 2-year results of a feasibility trialÂ were presented in the high-ranking Annals of Surgery in 2010. Â The article had T. DeMeester as one of the authors, the renown pioneer of gastroesophageal reflux diagnostics and treatment. The highly sophisticated device, . . . → Read More: Magnetic device for heartburn and reflux: the disappointing early performance of LINX.
We were delighted to hear our abstract was chosen for poster presentation on May 20, 2013 at the Digestive Disease Week (DDW) at Orlando, FL. The latest results of the pilot study will be presented, which audits the symptom free survival after fundoplication with PTFE mesh hiatoplasty for heartburn and gastroesophageal reflux disease. The results are . . . → Read More: DDW 2013 Orlando/FL Update on ePTFE mesh in Hiatal Hernia Repair and Fundoplication for Gastroesophageal Reflux
Recent population based large trials have lowered the assumed propensity of Barrett esophagus (BE) to develop into adenocarcinoma. The good news is that esophageal cancer can now be expected to develop at a yearly rate of only 0.12 % in subjects with non-dysplastic BE.
The question remains which next actions should be aimed at in subjects with . . . → Read More: Risk factors for esophageal adenocarcinoma – what can be changed?
LINX was launched some four years ago, and was implanted in a small group of patients at the Vienna University hospital recently. A chain of magnetic titanium beads is implanted laparoscopically around the lower esophageal sphincter. It relaxes during swallowing only and prevents gastric contents to spill backwards such as in gastroesophageal reflux disease (GERD). The . . . → Read More: LINX – a promising new simple operation for reflux and heartburn but not for hiatus hernia
“Radiofrequency ablation (RFA; the HALO procedure) was shown to be safe and effective in patients who had previously been treated with fundoplication, according to new research presented ” at DDW 2012 San Diego.
We were delighted to hear that, but how about the other way round? Â Will fundoplication after previous, sometimes multiple RFA applications be as easily . . . → Read More: RFA, fundoplication and complications
A session presented by speakers from Greece, Germany, Austria and the Netherlands was dedicated to fundoplication for gastroesophageal reflux. Dr. Theodorou from Athens gave an overwiew on preoperative workup. He stressed that patient history, i.e. whether typical reflux symptoms prevail and proton pump inhibitors were effective and endoscopy are the preeminently important considerations before fundoplication. He . . . → Read More: Laparoscopic fundoplication at the 20th congress of the EAES in Brussels June 20-23 2012.
a pilot series presented at the 53rd Congress of the Austrian Society for Surgery reported the promising short term results when applied with fundoplication for gatroesopahgeal reflux disease with hiatal hernia. After a mean follow-up of 14 months no recurrence of reflux symptoms such as heartburn occurred in the 19 cases who had a Nissen fundoplication . . . → Read More: Promising technique for hiatal hernia repair using Goretex dual mesh
Wels, the ancient Ovilava, hosts this yearâ€™s meeting of the Austrian Society for Gastroenterology and Hepatology. Some decent abstracts have been published in advance. A report on radio frequency ablation (RFA, HALO) from the department of gastroenterology of a Viennese community hospital (Rudolfstiftung) stands out with itâ€™s use of the new procedure on non-dysplastic, and dysplastic . . . → Read More: Thougths on radio frequency ablation (RFA) for Barrettâ€™s esophagus: an over-used modality?
Cutting edge news on the treatment of Barrettâ€™s esophagus have been communicated in a series of fine review presentations. The good news in a nutshell:
Barrettâ€™ s esophagus proceeds to cancer less often than has been thought before. Intestinal metaplasia at the esophagogastric junction without low grade dysplasia proceeds to severe dysplasia or cancer in only 0.1 . . . → Read More: Letter from San Diego DDW2012: Barrett’s esophagus